BR112019024040A2 - peptídeo e composição farmacêutica para tratamen-to de doenças oculares comprendendo o mesmo peptídeo como ingrediente ativo - Google Patents
peptídeo e composição farmacêutica para tratamen-to de doenças oculares comprendendo o mesmo peptídeo como ingrediente ativo Download PDFInfo
- Publication number
- BR112019024040A2 BR112019024040A2 BR112019024040-3A BR112019024040A BR112019024040A2 BR 112019024040 A2 BR112019024040 A2 BR 112019024040A2 BR 112019024040 A BR112019024040 A BR 112019024040A BR 112019024040 A2 BR112019024040 A2 BR 112019024040A2
- Authority
- BR
- Brazil
- Prior art keywords
- gly
- leu
- ala
- yde
- gln
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ophthalmology & Optometry (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20170061250 | 2017-05-17 | ||
| KR10-2017-0061250 | 2017-05-17 | ||
| PCT/KR2018/005673 WO2018225961A1 (ko) | 2017-05-17 | 2018-05-17 | 신규한 펩타이드 및 이를 유효성분으로 포함하는 안구질환 치료용 약학 조성물 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112019024040A2 true BR112019024040A2 (pt) | 2020-09-24 |
Family
ID=64566301
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112019024040-3A BR112019024040A2 (pt) | 2017-05-17 | 2018-05-17 | peptídeo e composição farmacêutica para tratamen-to de doenças oculares comprendendo o mesmo peptídeo como ingrediente ativo |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US12037415B2 (https=) |
| EP (1) | EP3643723B1 (https=) |
| JP (2) | JP7680824B2 (https=) |
| KR (2) | KR102287226B1 (https=) |
| CN (1) | CN110945012A (https=) |
| AU (1) | AU2018281617B2 (https=) |
| BR (1) | BR112019024040A2 (https=) |
| CA (1) | CA3063842A1 (https=) |
| ES (1) | ES2982308T3 (https=) |
| MX (1) | MX2019013799A (https=) |
| RU (1) | RU2766160C2 (https=) |
| SG (1) | SG11201912110YA (https=) |
| WO (1) | WO2018225961A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102287226B1 (ko) | 2017-05-17 | 2021-08-11 | 주식회사 유유제약 | 신규한 펩타이드 및 이를 유효성분으로 포함하는 안구질환 치료용 약학 조성물 |
| US11613558B2 (en) | 2018-11-14 | 2023-03-28 | Yuyu Pharma, Inc. | Peptides and pharmaceutical compositions for treating eye diseases |
| TWI865470B (zh) * | 2018-11-14 | 2024-12-11 | 南韓商柳柳製藥股份有限公司 | 治療眼睛疾病之肽及醫藥組合物 |
| JP7576048B2 (ja) * | 2019-05-21 | 2024-10-30 | アイバイオ コリア | 新規なペプチド化合物またはその薬学的に許容される塩 |
| KR20210104460A (ko) * | 2020-02-17 | 2021-08-25 | 주식회사 아이바이오코리아 | 고체상 합성법을 이용한 펩타이드의 제조 방법 |
| EP4114430A4 (en) * | 2020-03-05 | 2025-05-14 | YUYU Pharma, Inc. | TREATMENT OF INFLAMMATORY DISEASES WITH PEPTIDES AND PHARMACEUTICAL COMPOSITIONS |
| KR102593936B1 (ko) * | 2021-12-13 | 2023-10-27 | 주식회사 아이바이오코리아 | 신규한 펩타이드를 포함하는 황반변성의 치료용 조성물 |
| AU2022412618B2 (en) * | 2021-12-13 | 2026-02-19 | Eyebiokorea, Inc. | Composition for treating macular degeneration comprising novel peptide |
| KR102587729B1 (ko) * | 2023-02-27 | 2023-10-12 | 주식회사 아이바이오코리아 | 펩타이드를 포함하는 당뇨망막병증의 치료용 조성물 |
| KR102673860B1 (ko) * | 2023-08-10 | 2024-06-12 | (주)케어젠 | 안구 건조증의 개선 활성을 갖는 펩타이드 및 이의 용도 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6037135A (en) * | 1992-08-07 | 2000-03-14 | Epimmune Inc. | Methods for making HLA binding peptides and their uses |
| WO2007117444A2 (en) * | 2006-03-31 | 2007-10-18 | Yinghe Hu | Protein detection by aptamers |
| US10611818B2 (en) | 2007-09-27 | 2020-04-07 | Agilent Technologies, Inc. | MHC multimers in tuberculosis diagnostics, vaccine and therapeutics |
| US20090131303A1 (en) * | 2007-11-16 | 2009-05-21 | Bor-Shyue Hong | Methods and compositions for treating dry eye |
| JP4490498B2 (ja) | 2008-09-30 | 2010-06-23 | 新田ゼラチン株式会社 | 疾病抑制剤 |
| CA2836946C (en) * | 2011-05-27 | 2017-08-01 | Allergan, Inc. | A crystalline form of cyclosporine a, methods of preparation, and methods for use thereof |
| MX2014006399A (es) * | 2011-11-30 | 2015-04-10 | Xigen Inflammation Ltd | Uso de inhibidores de peptidos con celulas permeables de la via para transduccion de señal de jnk para el tratamiento de la queratoconjuntivitis seca. |
| KR101438744B1 (ko) * | 2012-08-02 | 2014-09-15 | 전남대학교산학협력단 | 아디포넥틴을 유효성분으로 포함하는 안구건조증 또는 염증성 안구표면 질환의 예방 또는 치료용 조성물 |
| KR101555296B1 (ko) | 2013-12-10 | 2015-09-23 | 인제대학교 산학협력단 | 연골세포 유래 세포외 기질을 유효성분으로 함유하는 건성안 예방 또는 치료용 약학조성물 |
| KR101948156B1 (ko) | 2013-12-10 | 2019-02-14 | 인제대학교 산학협력단 | 알칼리 화상을 이용한 각막 혼탁증 동물모델 및 각막 혼탁증 예방 또는 치료용 약학조성물 |
| KR101721059B1 (ko) | 2014-12-26 | 2017-03-30 | 주식회사 아이바이오코리아 | 안구 표면 질환 예방 또는 치료용 약학조성물 |
| KR101690539B1 (ko) | 2015-07-30 | 2016-12-29 | 주식회사 아이바이오코리아 | 건성안 예방 또는 치료용 약학조성물 |
| TWI675851B (zh) | 2015-12-14 | 2019-11-01 | 台灣基督長老教會馬偕醫療財團法人馬偕紀念醫院 | 短合成胜肽及其用途 |
| CN109310731B (zh) * | 2016-04-08 | 2022-03-29 | 韩国视角生物株式会社 | 软骨细胞的细胞外基质来源的肽 |
| KR101798183B1 (ko) * | 2016-04-08 | 2017-11-15 | 주식회사 아이바이오코리아 | 건성안 예방 또는 치료용 약학조성물 |
| KR101795653B1 (ko) | 2016-05-19 | 2017-11-09 | 인제대학교 산학협력단 | 콜라겐 타입 ii 펩타이드-아플리버셉트의 키메라 단백질을 유효성분으로 함유하는 혈관신생 억제용 조성물 |
| KR20180074928A (ko) | 2016-12-26 | 2018-07-04 | 주식회사 아이바이오코리아 | 건성안 예방 또는 치료용 동물 의약품 조성물 |
| KR102287226B1 (ko) | 2017-05-17 | 2021-08-11 | 주식회사 유유제약 | 신규한 펩타이드 및 이를 유효성분으로 포함하는 안구질환 치료용 약학 조성물 |
| TWI865470B (zh) * | 2018-11-14 | 2024-12-11 | 南韓商柳柳製藥股份有限公司 | 治療眼睛疾病之肽及醫藥組合物 |
| US11613558B2 (en) | 2018-11-14 | 2023-03-28 | Yuyu Pharma, Inc. | Peptides and pharmaceutical compositions for treating eye diseases |
| EP4114430A4 (en) * | 2020-03-05 | 2025-05-14 | YUYU Pharma, Inc. | TREATMENT OF INFLAMMATORY DISEASES WITH PEPTIDES AND PHARMACEUTICAL COMPOSITIONS |
-
2018
- 2018-05-17 KR KR1020180056745A patent/KR102287226B1/ko active Active
- 2018-05-17 BR BR112019024040-3A patent/BR112019024040A2/pt unknown
- 2018-05-17 EP EP18812841.7A patent/EP3643723B1/en active Active
- 2018-05-17 MX MX2019013799A patent/MX2019013799A/es unknown
- 2018-05-17 JP JP2019563617A patent/JP7680824B2/ja active Active
- 2018-05-17 SG SG11201912110YA patent/SG11201912110YA/en unknown
- 2018-05-17 RU RU2019141646A patent/RU2766160C2/ru active
- 2018-05-17 CN CN201880047540.1A patent/CN110945012A/zh active Pending
- 2018-05-17 US US16/614,123 patent/US12037415B2/en active Active
- 2018-05-17 WO PCT/KR2018/005673 patent/WO2018225961A1/ko not_active Ceased
- 2018-05-17 ES ES18812841T patent/ES2982308T3/es active Active
- 2018-05-17 CA CA3063842A patent/CA3063842A1/en active Pending
- 2018-05-17 AU AU2018281617A patent/AU2018281617B2/en active Active
-
2021
- 2021-07-30 KR KR1020210100394A patent/KR102498428B1/ko active Active
-
2023
- 2023-04-05 JP JP2023061251A patent/JP7775250B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2018281617B2 (en) | 2022-06-30 |
| SG11201912110YA (en) | 2020-01-30 |
| EP3643723B1 (en) | 2024-05-15 |
| RU2019141646A3 (https=) | 2021-07-28 |
| ES2982308T3 (es) | 2024-10-15 |
| JP2023098936A (ja) | 2023-07-11 |
| RU2019141646A (ru) | 2021-06-17 |
| JP2020520372A (ja) | 2020-07-09 |
| CN110945012A (zh) | 2020-03-31 |
| US12037415B2 (en) | 2024-07-16 |
| US20210024577A1 (en) | 2021-01-28 |
| RU2766160C2 (ru) | 2022-02-08 |
| EP3643723C0 (en) | 2024-05-15 |
| MX2019013799A (es) | 2020-08-13 |
| KR102498428B1 (ko) | 2023-02-20 |
| EP3643723A1 (en) | 2020-04-29 |
| CA3063842A1 (en) | 2019-12-09 |
| AU2018281617A1 (en) | 2019-12-05 |
| KR20210097670A (ko) | 2021-08-09 |
| EP3643723A4 (en) | 2021-03-31 |
| WO2018225961A1 (ko) | 2018-12-13 |
| KR102287226B1 (ko) | 2021-08-11 |
| KR20180126406A (ko) | 2018-11-27 |
| JP7775250B2 (ja) | 2025-11-25 |
| JP7680824B2 (ja) | 2025-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7775250B2 (ja) | 新規ペプチド及びその新規ペプチドを活性成分として含む眼疾患の治療のための医薬組成物 | |
| JP7522732B2 (ja) | 眼疾患治療用のペプチド及び医薬組成物 | |
| JP6994454B2 (ja) | ベンズアゾール化合物ならびに該化合物の作製方法および使用方法 | |
| TW200838536A (en) | Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor | |
| WO2024088409A1 (zh) | 一种含氮杂环化合物、其药学上可接受的盐及其制备方法与应用 | |
| WO2021191689A2 (en) | Treatment of inflammatory diseases with peptides and pharmaceutical compositions | |
| CN102665716B (zh) | 用于治疗唐氏综合征的方法和药物组合物 | |
| WO2020143604A1 (zh) | 一种二氢异喹啉类化合物 | |
| JP2022106788A (ja) | 脂質化ペプチドの水溶性塩、その製造方法および用途 | |
| CA3119921C (en) | Peptides and pharmaceutical compositions for treating eye diseases | |
| RU2819399C2 (ru) | Пептиды и фармацевтические композиции для лечения глазных болезней | |
| WO2022166923A1 (zh) | 苯基二氢嘧啶类化合物及其应用 | |
| HK40017864A (en) | Novel peptide and pharmaceutical composition for treatment of eye diseases comprising same novel peptide as active ingredient | |
| CN100422161C (zh) | 羟基吗啉酮衍生物及其医药用途 | |
| HK40061089B (zh) | 用於治疗眼病的肽和药物组合物 | |
| HK40061089A (en) | Peptides and pharmaceutical compositions for treating eye diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] |